Join the Jantoven group to help and get support from people like you.
Jantoven News
Newer Blood Thinner Edoxaban Cuts Odds for Stroke After Heart Valve Surgery
TUESDAY, Nov. 19, 2024 – Japanese researchers say they have found a pill that works as well as existing medication to prevent blood clots after heart valve surgery, with fewer trips to the doctor....
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
MONDAY, July 8, 2024 – For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major...
FDA Medwatch Alert: Coumadin (warfarin sodium) for Injection by Bristol-Myers Squibb: Recall - Particulate Matter
ISSUE: Bristol-Myers Squibb Company issued a voluntary recall of six lots of Coumadin for Injection, 5 mg single-use vials in the U.S. Visible particulate matter was found in a small number of ...
FDA Medwatch Alert: Warfarin 2 mg Tablets by Zydus Pharmaceuticals USA Inc.: Recall - Due to Oversized Tablets
ISSUE: Zydus Pharmaceuticals USA Inc. is voluntarily recalling one lot of Warfarin 2 mg Tablets, Lot #MM5767, expiration date June 2014 to the retail level. Four tablets of Warfarin 2 mg Tablets, Lot...
Further information
Related condition support groups
Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Deep Vein Thrombosis - First Event, Deep Vein Thrombosis - Recurrent Event, Myocardial Infarction, Heart Attack, Heart Failure, Congestive Heart Failure, Prevention of Thromboembolism in Atrial Fibrillation, Pulmonary Embolism - First Event, Pulmonary Embolism - Recurrent Event, Thromboembolic Stroke Prophylaxis